Opendata, web and dolomites

TACTICS

Transferring Activomics into the Clinical Setting

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 TACTICS project word cloud

Explore the words cloud of the TACTICS project. It provides you a very rough idea of what is the project "TACTICS" about.

disease    economic    milestone    sme    sought    sufferers    elisa    breakthrough    alone    differentiate    cell    proteomics    subset    unhealthy    market    prognostics    laboratories    heavy    promises    controls    inflammatory    public    serological    focussed    blood    people    private    burden    accuracy    activomics    disruptive    86    transferring    vital    counts    sera    emphasis    linked    activomic    clinical    detect    diagnostic    diagnostics    led    unlike    toll    millions    reduce    therapy    sensitive    debilitating    marker    concomitant    ms    screening    million    alike    protein    act    worldwide    business    taxpayer    progression    health    biomarkers    suffering    switches    utility    patients    validate    concentration    inextricably    participate    enzymatic    introduction    tool    roadmap    bowel    advancing    signalling    tactics    devise    proprietary    enzymes    cohorts    proteins    sensitivity    ibd    plan    first    healthy    setting    discovery    investment    patient    diagnosis    healthcare    global    laboratory    biomarker   

Project "TACTICS" data sheet

The following table provides information about the project.

Coordinator
IP RESEARCH CONSULTING SASU 

Organization address
address: QUAI DES DEUX PONTS 31
city: NOISY LE GRAND
postcode: 93160
website: www.photeomix.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website http://www.activomics.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-12-01   to  2016-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IP RESEARCH CONSULTING SASU FR (NOISY LE GRAND) coordinator 50˙000.00

Map

 Project objective

Transferring Activomics into the Clinical Setting (TACTICS). Advancing our proprietary biomarker discovery tool, Activomics, into the clinical laboratory represents an exciting milestone in the introduction of this disruptive technology to the global diagnostics market. Unlike current protein-concentration focussed diagnostics, such as ELISA and MS proteomics, our approach switches the emphasis towards the enzymatic activities of a subset of these proteins, vital cell-signalling enzymes inextricably linked to disease and its progression. We have developed highly sensitive methods to detect Activomic biomarkers in blood. Screening of sera obtained from large patient cohorts led us to identify a novel Activomic biomarker that can differentiate IBD (Inflammatory Bowel Disease) patients from healthy and unhealthy controls with high accuracy (86%) and sensitivity (86%). This first effective serological marker for IBD promises to be a major breakthrough in the diagnostics and/or prognostics of this debilitating disease that counts millions of sufferers worldwide. In Europe alone, over 1 million people currently have the disease, bringing with it a major toll on public health and a concomitant heavy economic burden for the healthcare system and taxpayer. Better diagnosis and targeted therapy of IBD would reduce suffering and costs alike. We participate in this call in order to achieve this goal, allowing us to devise a comprehensive business plan that will act as a roadmap to bring our biomarker into clinical diagnostic laboratories. SME-phase 2 funding and/or further private investment will be sought using the detailed business plan in order to fully validate clinical utility.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TACTICS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TACTICS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

DIAdIC (2019)

Evaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial

Read More  

ENDOSCAPE (2019)

ENDOSCAPE, a clinically applicable non-viral gene delivery technology

Read More  

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More